Osaka, Japan

Yasuko Matsumura

USPTO Granted Patents = 5 


Average Co-Inventor Count = 1.8

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Yasuko Matsumura in Ophthalmic Compositions

Introduction

Yasuko Matsumura is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of ophthalmology through his innovative patents. With a total of five patents to his name, Matsumura's work focuses on enhancing ophthalmic compositions for better efficacy and stability.

Latest Patents

Matsumura's latest patents include an ophthalmic composition that comprises a combination of terpenoid, tocopherol, and a benzyl ammonium compound. This composition is designed to be contained in a specialized container made from a resin containing a cyclic olefin. Another aspect of his innovation involves an ophthalmic composition that includes a surface-active component and a buffer, also contained in a cyclic olefin resin container. Additionally, he has developed an aqueous ophthalmic composition that contains terpenoid, zinc chloride, and various polymeric compounds. This composition aims to inhibit the adsorption of terpenoid to the container, thereby maintaining its content over time and providing beneficial actions such as inhibiting histamine release and reducing eye discharges.

Career Highlights

Matsumura is currently associated with Rohto Pharmaceutical Co., Ltd., where he continues to advance his research and development in ophthalmic solutions. His work has been instrumental in creating formulations that improve patient outcomes in eye care.

Collaborations

Matsumura has collaborated with notable colleagues, including Kazuhiro Fukushima and Chinatsu Furumiya, who contribute to the innovative projects at Rohto Pharmaceutical Co., Ltd. Their teamwork enhances the development of effective ophthalmic products.

Conclusion

Yasuko Matsumura's contributions to ophthalmic compositions reflect his dedication to improving eye care through innovation. His patents demonstrate a commitment to enhancing the stability and efficacy of ophthalmic solutions, benefiting both the industry and patients alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…